Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.

Saved in:
Bibliographic Details
Title: Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.
Authors: Naeger LK; Division of Antiviral Products, Center for New Drug Evaluation, Food and Drug Administration, Silver Spring, Maryland, USA. lisa.naeger@fda.hhs.gov, Struble KA
Source: AIDS (London, England) [AIDS] 2007 Jan 11; Vol. 21 (2), pp. 179-85.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Print ISSN: 0269-9370 (Print) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0269-9370
DOI:10.1097/QAD.0b013e3280119213